Mirae Asset Global Investments
FOLD

Mirae Asset Global Investments’s Amicus Therapeutics FOLD Stock Holding History

Mirae Asset Global Investments’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,993
Closed -$214K – 1636
2025
Q4 		$214K Buy
14,993
+3,076
+26% +$30.2K ﹤0.01% 1136
2025
Q3 		$93.9K Buy
11,917
+22
+0.2% +$157 ﹤0.01% 1228
2025
Q2 		$68.2K Buy
11,895
+1,614
+16% +$10.4K ﹤0.01% 1210
2025
Q1 		$86.7K Buy
10,281
+324
+3% +$3K ﹤0.01% 1141
2024
Q4 		$95.9K Sell
9,957
-770
-7% -$8K ﹤0.01% 1153
2024
Q3 		$115K Buy
10,727
+1,884
+21% +$20.5K ﹤0.01% 1164
2024
Q2 		$87.6K Sell
8,843
-203,042
-96% -$2.08M ﹤0.01% 1157
2024
Q1 		$2.39M Sell
211,885
-17,719
-8% -$227K 0.01% 1112
2023
Q4 		$3.26M Buy
229,604
+19,204
+9% +$218K 0.01% 1052
2023
Q3 		$2.56M Sell
210,400
-8,737
-4% -$113K 0.01% 1085
2023
Q2 		$2.75M Buy
219,137
+9,088
+4% +$108K 0.01% 1064
2023
Q1 		$2.33M Buy
210,049
+23,937
+13% +$295K 0.01% 1142
2022
Q4 		$2.27M Sell
186,112
-5,276
-3% -$59.4K 0.01% 1087
2022
Q3 		$2M Buy
191,388
+16,040
+9% +$179K 0.01% 1137
2022
Q2 		$1.88M Buy
+175,348
New +$1.44M ﹤0.01% 1155
2021
Q2 		– Sell
-94,611
Closed -$935K – 1707
2021
Q1 		$935K Buy
94,611
+39,643
+72% +$614K ﹤0.01% 1148
2020
Q4 		$1.27M Sell
54,968
-20,900
-28% -$427K ﹤0.01% 1070
2020
Q3 		$1.07M Buy
+75,868
New +$1.11M 0.01% 947
2020
Q1 		– Sell
-106,898
Closed -$1.04M – 1441
2019
Q4 		$1.04M Buy
106,898
+9,007
+9% +$82.4K 0.01% 951
2019
Q3 		$785K Buy
+97,891
New +$1.06M 0.01% 993

Other funds holding FOLD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Mirae Asset Global Investments's FOLD Position: Q1 2026 in Review

Mirae Asset Global Investments sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 14,993 shares — an estimated $214K sold.

Mirae Asset Global Investments first reported a position in FOLD in Q3 2019 and held it in 20 quarters. The position peaked at $3.26M in Q4 2023. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Mirae Asset Global Investments reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Mirae Asset Global Investments sold 14,993 Amicus Therapeutics shares in Q1 2026, an estimated $214K.
  • Mirae Asset Global Investments first reported a position in Amicus Therapeutics in Q3 2019 and held it in 20 quarters.
  • Mirae Asset Global Investments's Amicus Therapeutics position peaked at $3.26M in Q4 2023.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Mirae Asset Global Investments's 13F filing for Q1 2026, filed 4 May 2026.